NO20024578D0 - Inhibition of angiogenesis and tumor growth - Google Patents

Inhibition of angiogenesis and tumor growth

Info

Publication number
NO20024578D0
NO20024578D0 NO20024578A NO20024578A NO20024578D0 NO 20024578 D0 NO20024578 D0 NO 20024578D0 NO 20024578 A NO20024578 A NO 20024578A NO 20024578 A NO20024578 A NO 20024578A NO 20024578 D0 NO20024578 D0 NO 20024578D0
Authority
NO
Norway
Prior art keywords
angiogenesis
inhibition
tumor growth
tumor
growth
Prior art date
Application number
NO20024578A
Other languages
Norwegian (no)
Other versions
NO328969B1 (en
NO20024578L (en
Inventor
Dale L Boger
David A Cheresh
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20024578D0 publication Critical patent/NO20024578D0/en
Publication of NO20024578L publication Critical patent/NO20024578L/en
Publication of NO328969B1 publication Critical patent/NO328969B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
NO20024578A 2000-03-27 2002-09-24 Compounds, compositions and uses thereof NO328969B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27
PCT/US2001/009756 WO2001072699A1 (en) 2000-03-27 2001-03-27 Inhibition of angiogenesis and tumor growth

Publications (3)

Publication Number Publication Date
NO20024578D0 true NO20024578D0 (en) 2002-09-24
NO20024578L NO20024578L (en) 2002-11-20
NO328969B1 NO328969B1 (en) 2010-06-28

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20024578A NO328969B1 (en) 2000-03-27 2002-09-24 Compounds, compositions and uses thereof
NO20024576A NO20024576L (en) 2000-03-27 2002-09-24 Method of Inhibiting Angiogenesis and Tumor Growth

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20024576A NO20024576L (en) 2000-03-27 2002-09-24 Method of Inhibiting Angiogenesis and Tumor Growth

Country Status (15)

Country Link
EP (2) EP1272173A4 (en)
JP (2) JP2003528850A (en)
KR (2) KR100776185B1 (en)
CN (2) CN1245967C (en)
AU (4) AU4949901A (en)
CA (3) CA2659030A1 (en)
CZ (2) CZ20023509A3 (en)
HU (2) HUP0301797A3 (en)
MX (2) MXPA02009504A (en)
NO (2) NO328969B1 (en)
PL (2) PL358272A1 (en)
RU (2) RU2269339C2 (en)
SK (2) SK14842002A3 (en)
WO (2) WO2001072297A1 (en)
ZA (2) ZA200208626B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1675573E (en) 2003-10-23 2008-12-30 Otsuka Pharma Co Ltd Controlled release sterile injectable aripiprazole formulation and method
RU2483711C2 (en) 2007-07-31 2013-06-10 Оцука Фармасьютикал Ко., Лтд. Methods of obtaining aripiprazole suspension and lyophilysed composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (en) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd New amide compound or its salt
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
BR9712794A (en) * 1996-09-04 1999-12-14 Warner Lambert Co Compounds for and a method of inhibiting matrix metalloproteinases
JP2001512441A (en) * 1997-02-07 2001-08-21 ザ スクリップス リサーチ インスティテュート Convergent synthesis of combinatorial libraries
IL138297A0 (en) * 1998-03-27 2001-10-31 Genentech Inc Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders

Also Published As

Publication number Publication date
NO20024576L (en) 2002-11-20
NO20024576D0 (en) 2002-09-24
EP1276713A4 (en) 2006-05-03
CN1441777A (en) 2003-09-10
NO328969B1 (en) 2010-06-28
MXPA02009510A (en) 2003-05-21
CA2403630C (en) 2009-05-26
SK14842002A3 (en) 2003-04-01
AU2001249499B2 (en) 2005-04-21
SK14852002A3 (en) 2003-06-03
PL366316A1 (en) 2005-01-24
CN1245967C (en) 2006-03-22
RU2002128751A (en) 2004-03-10
NO20024578L (en) 2002-11-20
CN1429106A (en) 2003-07-09
KR20020091156A (en) 2002-12-05
RU2276133C2 (en) 2006-05-10
MXPA02009504A (en) 2003-05-21
AU2001251018B2 (en) 2005-12-01
EP1276713A1 (en) 2003-01-22
HUP0301621A2 (en) 2003-09-29
EP1272173A4 (en) 2006-05-03
CZ20023509A3 (en) 2003-06-18
JP2003528140A (en) 2003-09-24
AU5101801A (en) 2001-10-08
CZ20023510A3 (en) 2003-03-12
ZA200208628B (en) 2004-02-12
CA2659030A1 (en) 2001-10-04
HUP0301621A3 (en) 2009-06-29
EP1272173A1 (en) 2003-01-08
HUP0301797A3 (en) 2010-09-28
JP2003528850A (en) 2003-09-30
RU2269339C2 (en) 2006-02-10
PL205134B1 (en) 2010-03-31
ZA200208626B (en) 2004-02-16
HUP0301797A2 (en) 2003-09-29
WO2001072699A1 (en) 2001-10-04
CA2403630A1 (en) 2001-10-04
PL358272A1 (en) 2004-08-09
CA2403871C (en) 2010-05-11
WO2001072297A1 (en) 2001-10-04
CN1229339C (en) 2005-11-30
KR100767616B1 (en) 2007-10-18
KR20020084258A (en) 2002-11-04
AU4949901A (en) 2001-10-08
CA2403871A1 (en) 2001-10-04
KR100776185B1 (en) 2007-11-16

Similar Documents

Publication Publication Date Title
EP1097165A4 (en) Novel inhibitors of angiogenesis and tumor growth
NO20024627D0 (en) Inhibition of cyclooxygenase-1 activity
NO20030725D0 (en) Therapeutic combination of CETP inhibitor and atorvastatin
NO20025792L (en) Quinazoline derivatives for the treatment of tumors
NO20025377D0 (en) Process for the preparation of dihydroxy esters and derivatives thereof
AU2600800A (en) Promotion or inhibition of angiogenesis and cardiovascularization
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20015516D0 (en) Preparations and uses of ET743 for the treatment of cancer
NO20024486L (en) Improved treatment of neovascularization
NO20011026D0 (en) Foodstuffs and methods of manufacture thereof
NO20000315D0 (en) Growth inhibition of shellfish and aquaculture devices
NO20023837D0 (en) Modulation of bone formation
AU2596700A (en) Promotion or inhibition of angiogenesis and cardiovascularization
NO20024776D0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20024236L (en) Treatment of psoriasis
NO20030978L (en) Treatment of urinary dysfunction
NO20024578L (en) Inhibition of angiogenesis and tumor growth
IS6707A (en) Preparation for the prevention and treatment of cancer
PT1272456E (en) HYDRAZIDE ANGIOGENESIS AND ALCOXYAMIDE INHIBITORS
NO20004109L (en) Stabilization of formations
NO20014845D0 (en) Use of arylalkanoylpyridazines
NO20042126L (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
AU2001268670A1 (en) Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
FI20001451A (en) Repositioning of glassworking bodies

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees